- Home
- PBR vs BMY Comparison
PBR vs BMY Comparison
Compare PBR & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBR | BMY |
|---|---|---|
| Founded | 1953 | 1887 |
| Country | Brazil | United States |
| Employees | 50687 | 32500 |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.7B | 113.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PBR | BMY |
|---|---|---|
| Price | $16.28 | $57.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | $17.56 | ★ $61.73 |
| AVG Volume (30 Days) | ★ 14.2M | 12.1M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | 3.31% | ★ 4.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $13.55 | $17.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.43 | $42.52 |
| 52 Week High | $22.24 | $62.89 |
Technical Indicators
Market Signals| Indicator | PBR | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 26.55 | 54.26 |
| Support Level | $11.49 | $56.36 |
| Resistance Level | $18.51 | $57.43 |
| Average True Range (ATR) | 0.38 | 1.38 |
| MACD | -0.06 | 0.11 |
| Stochastic Oscillator | 3.67 | 85.81 |
Price Performance
Historical ComparisonAbout PBR Petroleo Brasileiro S.A.- Petrobras
Petrobras is a Brazil-based integrated energy company controlled by the Brazilian government. The company focuses on the exploration and production of oil and gas in Brazilian offshore fields. Production in 2025 was 3.0 million barrels of oil equivalent per day (80% oil), and reserves stood at 12.1 billion boe (84% oil). At the end of 2025, Petrobras operated 10 refineries in Brazil with a capacity of 1.8 million barrels per day and distributed refined products and natural gas throughout the country.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.